Investegate |Synairgen plc Announcements | Synairgen plc: Data from the US NIH-led ACTIV-2 Phase 2 trial

Investegate announcements from Synairgen plc, Data from the US NIH-led ACTIV-2 Phase 2 trial

Related Keywords

Namrata Taak ,Geoff Nash ,Mary Conway ,Richard Marsden ,Donna Davies ,Duncan Monteith ,Brooke Clarke ,William Fischer ,James Black ,Mary Jane Elliott ,Ratko Djukanovic ,Freddie Barnfield ,Lucy Featherstone ,Numis Securities Limited Joint Broker ,Head Of Communications ,National Institutes Of Health ,Clinical Trials Group ,Drug Administration ,University Of North Carolina ,Consilium Strategic Communications Financial Media ,Mkc Strategies Llc Us Media Relations ,University Of Southampton Professors Sir Stephen Holgate ,Us National Institutes Of Health ,Trials Group ,Adverse Events ,Independent Data Safety Monitoring Board ,North Carolina ,Joint Broker ,Charlie Beeson ,Corporate Finance ,Sunil De Silva ,Securities Limited ,Strategic Communications ,Financial Media ,Investor Relations ,Jane Elliott ,United Kingdom Based ,Fast Track ,Southampton Professors Sir Stephen Holgate ,Platform Treatment Trial ,National Institutes ,Investegate Announcements ,Investegate Company Announcements ,Synairgen Plc ,Egulatory News Service ,Egulatory News Service And Regulatory ,Ns ,